BRPI0414786A - extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo - Google Patents

extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo

Info

Publication number
BRPI0414786A
BRPI0414786A BRPI0414786-3A BRPI0414786A BRPI0414786A BR PI0414786 A BRPI0414786 A BR PI0414786A BR PI0414786 A BRPI0414786 A BR PI0414786A BR PI0414786 A BRPI0414786 A BR PI0414786A
Authority
BR
Brazil
Prior art keywords
mahonia aquifolium
aquifolium extract
pharmaceutical composition
extraction process
composition containing
Prior art date
Application number
BRPI0414786-3A
Other languages
English (en)
Inventor
Robert Mills
Rajiv Mathur
Nadya Lawrence
Original Assignee
Prime Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prime Pharmaceutical Corp filed Critical Prime Pharmaceutical Corp
Publication of BRPI0414786A publication Critical patent/BRPI0414786A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

"EXTRATO DE MAHONIA AQUIFOLIUM, PROCESSO DE EXTRAçãO E COMPOSIçãO FARMACêUTICA CONTENDO O MESMO". A presente invenção provê uma composição para o tratamento da pele compreendendo um extrato de Mahonia aquifolium em um sistema de liberação de lipossoma. O extrato de Mahonia aquifolium está presente na composição para o tratamento da pele em uma faixa de 5% a 20% em peso da composição total. A composição para o tratamento da pele é particularmente eficaz no tratamento de psoríase, eczema e outras condições de pele seca. A presente invenção provê ainda um processo para obtenção de um extrato de Mahonia aquifolium.
BRPI0414786-3A 2003-09-25 2004-09-22 extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo BRPI0414786A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/669,416 US7205006B2 (en) 2003-09-25 2003-09-25 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
PCT/CA2004/001726 WO2005027945A1 (en) 2003-09-25 2004-09-22 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

Publications (1)

Publication Number Publication Date
BRPI0414786A true BRPI0414786A (pt) 2006-11-21

Family

ID=34375887

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414786-3A BRPI0414786A (pt) 2003-09-25 2004-09-22 extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo

Country Status (16)

Country Link
US (2) US7205006B2 (pt)
EP (1) EP1663154B1 (pt)
JP (1) JP2007506685A (pt)
KR (1) KR20060069514A (pt)
CN (1) CN1856318B (pt)
AT (1) ATE488226T1 (pt)
AU (1) AU2004273556B2 (pt)
BR (1) BRPI0414786A (pt)
CA (1) CA2538867A1 (pt)
DE (1) DE602004030131D1 (pt)
IL (1) IL174206A (pt)
MX (1) MXPA06003146A (pt)
NZ (1) NZ545853A (pt)
RU (1) RU2388482C2 (pt)
WO (1) WO2005027945A1 (pt)
ZA (1) ZA200602143B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
ES2661728T3 (es) * 2005-10-03 2018-04-03 Pinksky, Mark A. Composiciones y métodos para el cuidado mejorado de la piel
CA2664944C (en) * 2006-09-28 2016-06-14 Hadasit Medical Research Services & Development Limited Use of glycerophospholipids for joint lubrication
JP6159084B2 (ja) * 2009-06-30 2017-07-05 デルマン バイオメディシン カンパニー リミテッド 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物
DE202010004750U1 (de) * 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
BR112012032153A2 (pt) * 2010-06-17 2017-08-08 Yeda Res And Development Company Ltd método para a lubrificação de uma ou mais superfícies não biológicas, método para a lubrificação de uma ou mais superfícies de um tecido biológico em um indivíduo mamífero, uso de lipossomas na fase em gel e lipossoma misto
DE102010030443A1 (de) * 2010-06-23 2011-01-05 Lr Health & Beauty Systems Gmbh Kosmetische Zusammensetzung und deren Verwendung
EP3313520A4 (en) * 2015-06-24 2019-01-02 TWI Biotechnology, Inc. Therapeutic uses of berberine formulations
GB2561818B (en) * 2017-03-30 2020-01-15 Phyto Sophos Ltd Plant extract compositions
IL272630B2 (en) 2017-08-22 2023-09-01 Moebius Medical Ltd Liposomal formulations for joint lubrication
JP6535146B1 (ja) * 2019-03-08 2019-06-26 佐藤製薬株式会社 皮膚バリア機能改善剤
CA3266614A1 (en) 2023-01-19 2024-07-25 Moebius Medical Ltd. LONG-ACTING LIPOSOMAL COMPOSITION FOR THE TREATMENT OF PAIN IN JOINT DISORDERS

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216317A (en) * 1879-06-10 Improvement in medical compounds
US3882244A (en) * 1971-12-13 1975-05-06 Univ California Method of treating acne with a c{hd 20 {b acid
US4054589A (en) * 1974-09-26 1977-10-18 Hoffmann-La Roche Inc. Novel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene esters
US4215215A (en) * 1975-08-01 1980-07-29 Hoffmann-La Roche Inc. 9-Phenyl-nonate traene compounds
US4105681A (en) * 1975-08-01 1978-08-08 Hoffmann-La Roche Inc. 9-phenyl 5,6-dimethyl-nona-2,4,6,8-tetraeonic acid compounds
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
JPS5738388Y2 (pt) * 1979-09-03 1982-08-24
SU931186A1 (ru) * 1979-12-19 1982-05-30 Пятигорский фармацевтический институт Способ получени берберина бисульфата
US4476056A (en) * 1982-11-05 1984-10-09 Hoffmann-La Roche Inc. Trifluoromethoxy analogs of aromatic retinoids
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
JPH07100685B2 (ja) * 1985-08-02 1995-11-01 レオ・ファ−マシュ−ティカル・プロダクツ・リミテッド・エイ／エス（レ−ベンス・ケミスケ・ファブリック・プロデュクチオンスアクチ−セルスカブ） 新規ビタミンｄ類似体
US4837378A (en) 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4713394A (en) * 1986-01-17 1987-12-15 Thornfeldt Carl R Treatment of nonacne inflammatory and infectious dermatoses and hair loss
US4767861A (en) * 1986-01-28 1988-08-30 Vipont Laboratories Recovery of benzo-c-phenanthridine alkaloids
US4865048A (en) * 1987-12-31 1989-09-12 Eckerson Harold D Method and apparatus for drug free neurostimulation
JPH0390022A (ja) * 1989-08-31 1991-04-16 Mochida Pharmaceut Co Ltd 皮膚疾患治療用外用剤
GB9004544D0 (en) * 1990-03-01 1990-04-25 Leo Pharm Prod Ltd Novel treatment ii
FR2673840A1 (fr) * 1991-03-14 1992-09-18 Lvmh Rech Composition cosmetique ou pharmaceutique, notamment dermatologique, contenant de l'oxyacanthine, en particulier destinee a stimuler la pousse des cheveux ou a retarder leur chute.
FR2684300B1 (fr) 1991-11-29 1994-03-11 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de ballote, et son procede de fabrication.
FR2699081B1 (fr) * 1992-12-11 1995-04-07 Lvmh Rech Utilisation d'un extrait de Simaba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
FR2699080B1 (fr) * 1992-12-11 1995-04-07 Lvmh Rech Utilisation d'un extrait de Simarouba pour l'atténuation des taches pigmentaires cutanées ou pour renforcer la fonction protectrice de la peau, ou pour la préparation d'un milieu de culture de cellules de peau, et composition ainsi obtenue.
CN1102993A (zh) * 1993-12-21 1995-05-31 吴文才 多酶体系加工中草药的制剂方法
FR2722098B1 (fr) * 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
CN2203180Y (zh) * 1994-08-22 1995-07-12 张仁忠 多功能提取罐
RU2157695C2 (ru) * 1995-02-03 2000-10-20 Ле Лабораториз Аетерна Инк. Экстракты хрящей акулы, способ их получения и применения
CA2214850A1 (en) * 1995-03-13 1996-09-19 Eli Lilly And Company Novel benzothiophene compounds and methods
US6271001B1 (en) * 1995-03-23 2001-08-07 Bio Polymers Pty. Ltd. Cultured plant cell gums for food, pharmaceutical, cosmetic and industrial applications
FR2734265B1 (fr) * 1995-05-17 1997-06-13 Adir Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
US5856487A (en) * 1996-02-14 1999-01-05 National Institute Of Immunology Application of protoberberine alkaloid, berberine, an immunosuppressive agent
PT892638E (pt) * 1996-04-04 2003-03-31 Cilag Ag Formulacao topica de vitamina d a base de lipossomas
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US6048902A (en) * 1999-02-12 2000-04-11 Lebwohl; Mark G. Short contact treatment of psoriasis with topical retinoids
US6210680B1 (en) 1999-06-11 2001-04-03 Univera Pharmaceuticals, Inc. Method for the prevention and treatment of chronic venous insufficiency
US6238696B1 (en) * 2000-01-07 2001-05-29 Gaia Herbs, Inc. Process for providing herbal medicants in cellulose derivative capsules
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US6254896B1 (en) * 2000-05-17 2001-07-03 Brent W. Davis Apparatus and process for in situ manufacture of essence from living, uncut plants
DE20109044U1 (de) * 2001-05-30 2001-08-09 Weber & Weber GmbH & Co. KG, 82266 Inning Pharmazeutische Zubereitung
US20030096422A1 (en) 2001-11-16 2003-05-22 Ong Eng Shi Pressurized liquid extraction method and apparatus
US20030185915A1 (en) * 2002-03-28 2003-10-02 Jaime Carlo Synergetic composition for the treatment of psoriasis and other skin disorders and method therefor
US20040043946A1 (en) * 2002-09-03 2004-03-04 Popp Karl F. Topical formulations for treatment of skin disorders
US7205006B2 (en) 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
IL174206A0 (en) 2006-08-01
IL174206A (en) 2011-03-31
JP2007506685A (ja) 2007-03-22
CA2538867A1 (en) 2005-03-31
AU2004273556A1 (en) 2005-03-31
CN1856318A (zh) 2006-11-01
ATE488226T1 (de) 2010-12-15
WO2005027945A1 (en) 2005-03-31
US20070148226A1 (en) 2007-06-28
AU2004273556B2 (en) 2010-12-02
EP1663154A1 (en) 2006-06-07
EP1663154B1 (en) 2010-11-17
RU2388482C2 (ru) 2010-05-10
NZ545853A (en) 2008-11-28
US7205006B2 (en) 2007-04-17
DE602004030131D1 (de) 2010-12-30
RU2006109188A (ru) 2007-10-27
MXPA06003146A (es) 2006-08-31
US20050069576A1 (en) 2005-03-31
EP1663154A4 (en) 2006-12-13
KR20060069514A (ko) 2006-06-21
ZA200602143B (en) 2007-09-26
CN1856318B (zh) 2010-05-26
US7621740B2 (en) 2009-11-24

Similar Documents

Publication Publication Date Title
BRPI0910874B8 (pt) formulação tópica para uso no tratamento tópico de uma condição da pele que resulta da produção de espécies reativas de oxigênio e/ou para a promoção da cicatrização de ferida tópica na pele de um indivíduo e uso da referida formulação
BRPI0412815A (pt) extrato de plantas com eficácia prebiótica
BRPI0609784C1 (pt) compostos éster de n-alquilcarbonil-aminoácido e n-alquilcarbonil-amino lactona, composição, e, uso de um composto
BRPI0414786A (pt) extrato de mahonia aquifolium, processo de extração e composição farmacêutica contendo o mesmo
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR112015014458A2 (pt) derivados de manose para o tratamento de infecções bacterianas
US20210212926A1 (en) Compositions including dendrobium nobile and methods of using same
BRPI0516177B8 (pt) oligorribonucleotídeos, uso dos mesmos, uso de um composto sirna eficaz para inibir 0 p53 humano e composição farmacêutica que os contém, bem como método para diminuição da expressão do gene p53
BR0309890A (pt) Composição farmacêutica contendo plasma sanguìneo, ou soro sanguìneo utilizada no tratamento de lesões, bem como seu método e processo de aplicação
BR112012016575A2 (pt) composição para cuidado da pele/dermatológica, fator de crescimento heterólogo produzido por planta, e, método para fabricar um produto tópico
BRPI0502346A (pt) processo de tratamento cosmético para prevenir e/ou tratar as peles sensìveis e/ou secas, utilização de uma quantidade eficaz de pelo menos um microorganismo notadamente probiótico e/ou uma de suas frações e/ou um de seus metabólitos e composição cosméticas e/ou dermatológica
EP1819227A4 (en) PHARMACEUTICAL FORMULATIONS OF DECITABIN
BR112015022819A8 (pt) método para a preparação de um taxano lipossomal, composição compreendendo um lipossoma e taxano lipossomal
BRPI0904268B8 (pt) processo cosmético de perfumação de uma matéria queratínica humana, composição perfumante aquosa, composições e processo cosmético de tratamento dos odores corporais humanos
BRPI0411503A (pt) composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto
GEP20135900B (en) Emollient composition
BRPI0410654A (pt) composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto
SI3057664T1 (en) Use of a composition for the pigmentation of hair and hairs
BRPI0410657A (pt) composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto
CN106074204A (zh) 一种染料木素衍生物在美白领域的应用
AU2015268649B9 (en) A composition and method of applying same & a composition that assists healing burns and wounds with antibacterial and anti-fungal actions
CN103126952A (zh) 红豆杉精油及红豆杉萃取物为原料的保健型香水品
CN105616230A (zh) 一种具有控油功效的乳液
Scarci et al. In vitro evaluations for a new topical anti-aging formulation
ATE357925T1 (de) Orale zusammensetzungen zur behandlung von cellulitis

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2169 DE 31/07/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 19/00 (2006.01), A61K 8/14 (2006.01), A61K 8/